Abstract:Objective To analyse the clinical characteristics,follow up their prognsis and evaluate the treatment of patients with Crohn' s disease (CD). Methods The data of patients with CD were collected at Zhongshan Hospital of Fudan University from 2002 to 2007. The diagnosis was made according to the consensus recommended by Chinese Society of Gastroenterology. The disease severity, follow-up and prognsis were evaluated according to the consensus. Results Sixty-six CD patients were enrolled in this study. The ratio of males to females was 2.47 : 1. Age at diagnosis ranged from 12 to 76 years old, and the mean age was (32 ± 17)years old. The main gastroenterological manifestations were abdominal pain (80.3 %), diarrhea (54.6 %), fistula formation (31.8%) ; and the main systemic manifestation was fever (80.3 %) and defective nutrition. A total of 60.6 % of patients with CD had complications and 34. 8% of these patients had more than one complications. Extraintestial manifastation were presented in 7.6% of patients with CD. A total of 86.4% of patients with CD were active state cases and 57. 6% were suffered from inflammation of ileum and colon. Abdominal pain (P = 0. 011), hematochezia (P = 0. 008), fever (P = 0. 001), anemia (P = 0. 020), underweight (P = 0. 010) and heightening of CRP (P = 0. 033) were more common in patients who were in active state than those who were in slient state. During their inducing alleviate treatment, 33.3% of patients with CD were treated with aminosalicylate alone, 36.4% were treated with both aminosalicylate and glucocorticoids, 7. 6% were treated with aminosalicylate, glucocorticoids and immunosuppressant. After medicine treatment, 6.8% of the patients relieved, 62.7% turned better, 28.8% were ineffective, 1.7% died, 55.9% recurd. And 21.2% were treated by surgical operation. A total of 42.4% of patients with CD had histroy of surgical operation and 9.1% were carried on more than one surgical operation.ConclusionsActive state patients with CD had high rate of complications, low extraintestial manifestatons, rare rate of dysplasia and canceration, and high rates of surgical operation and recurring.

The hematological characteristics of patients with Crohn's disease

Platelets can reflect the severity of Crohn's disease without the effect of anemia.

Anemia and iron deficiency in Crohn's disease.

Influence of altered coagulation and fibrinolysis status on disease activity of inflammatory bowel disease

Risks of Cardiovascular Events in Patients with Inflammatory Bowel Disease in China: A Retrospective Multicenter Cohort Study

Efficacy of Erythropoietin Combined with Enteral Nutrition for the Treatment of Anemia in Crohn'S Disease: A Prospective Cohort Study

The clinical characteristics and treatment evaluation of patients with Crohn's disease

Alterations of Th17/Treg Cells in Peripheral Blood and Serum Inflammatory Biomarkers in Patients with Crohn's Disease and Its Clinical Significance

Anemia of Chronic Disease in Patients With Cardiovascular Disease

Impaired Coagulation Status in the Crohn's Disease Patients Complicated with Intestinal Fistula

Coagulation state in patients with Crohn's disease: the effect of infliximab therapy.

Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables

Coagulation State in Patients with Crohn’s Disease

IDDF2018-ABS-0211 Altered coagulation in inflammatory bowel disease: predictors of the disease status

Monocyte CD36 Expression Predicts Disease Activity in Patients With Crohn's Disease

Mass cytometry and single-cell RNA sequencing reveal immune cell characteristics of active and inactive phases of Crohn’s disease

Value of Red Cell Distribution Width for Assessing Disease Activity in Crohn's Disease

Interaction between coagulation and inflammatory system in liver disease: re-focus on hematological markers

Serological Assessment of the Quality of Wound Healing Processes in Crohn's Disease

[Research Progress of Anemia Associated with Inflammatory Bowel Diseases].

Updated review on immune factors in pathogenesis of Crohn’s disease